Manulife (Manufacturers Life Insurance)’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.9K | Sell |
30,667
-17,544
| -36% | -$55.7K | ﹤0.01% | 2686 |
|
|
2025
Q4 | $193K | Sell |
48,211
-6,059
| -11% | -$33.7K | ﹤0.01% | 2542 |
|
|
2025
Q3 | $459K | Sell |
54,270
-4,566
| -8% | -$44.3K | ﹤0.01% | 2250 |
|
|
2025
Q2 | $662K | Sell |
58,836
-801
| -1% | -$7.36K | ﹤0.01% | 2029 |
|
|
2025
Q1 | $565K | Buy |
59,637
+1,746
| +3% | +$17.6K | ﹤0.01% | 2086 |
|
|
2024
Q4 | $651K | Sell |
57,891
-7,063
| -11% | -$124K | ﹤0.01% | 2105 |
|
|
2024
Q3 | $1.84M | Sell |
64,954
-2,545
| -4% | -$65.6K | ﹤0.01% | 1599 |
|
|
2024
Q2 | $1.29M | Buy |
67,499
+4,572
| +7% | +$117K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $2.06M | Buy |
62,927
+8,833
| +16% | +$282K | ﹤0.01% | 1505 |
|
|
2023
Q4 | $1.79M | Sell |
54,094
-913
| -2% | -$25.8K | ﹤0.01% | 1508 |
|
|
2023
Q3 | $1.5M | Buy |
55,007
+10,896
| +25% | +$303K | ﹤0.01% | 1533 |
|
|
2023
Q2 | $1.34M | Buy |
44,111
+10,562
| +31% | +$342K | ﹤0.01% | 1531 |
|
|
2023
Q1 | $1.09M | Buy |
33,549
+293
| +0.9% | +$9.27K | ﹤0.01% | 1590 |
|
|
2022
Q4 | $934K | Buy |
33,256
+402
| +1% | +$11.5K | ﹤0.01% | 1643 |
|
|
2022
Q3 | $1.18M | Sell |
32,854
-552
| -2% | -$19.4K | ﹤0.01% | 1538 |
|
|
2022
Q2 | $1.03M | Buy |
33,406
+411
| +1% | +$12K | ﹤0.01% | 1632 |
|
|
2022
Q1 | $1.07M | Sell |
32,995
-7,084
| -18% | -$185K | ﹤0.01% | 1721 |
|
|
2021
Q4 | $1.11K | Sell |
40,079
-221
| -0.5% | -$6.34K | ﹤0.01% | 1767 |
|
|
2021
Q3 | $1.25M | Sell |
40,300
-4,285
| -10% | -$103K | ﹤0.01% | 1699 |
|
|
2021
Q2 | $942K | Buy |
44,585
+1,411
| +3% | +$28.3K | ﹤0.01% | 2028 |
|
|
2021
Q1 | $872K | Sell |
43,174
-2,471
| -5% | -$47K | ﹤0.01% | 1971 |
|
|
2020
Q4 | $732K | Buy |
45,645
+1,441
| +3% | +$19K | ﹤0.01% | 2001 |
|
|
2020
Q3 | $549K | Sell |
44,204
-1,723
| -4% | -$20.3K | ﹤0.01% | 1956 |
|
|
2020
Q2 | $315K | Sell |
45,927
-2,402
| -5% | -$16.1K | ﹤0.01% | 2221 |
|
|
2020
Q1 | $262K | Buy |
48,329
+3,041
| +7% | +$27.2K | ﹤0.01% | 2176 |
|
|
2019
Q4 | $410K | Sell |
45,288
-477
| -1% | -$3.88K | ﹤0.01% | 2158 |
|
|
2019
Q3 | $332K | Hold |
45,765
| – | – | ﹤0.01% | 2261 |
|
|
2019
Q2 | $364K | Buy |
45,765
+932
| +2% | +$11K | ﹤0.01% | 2242 |
|
|
2019
Q1 | $564K | Buy |
44,833
+3,636
| +9% | +$57.6K | ﹤0.01% | 2015 |
|
|
2018
Q4 | $822K | Sell |
41,197
-3,380
| -8% | -$78.2K | ﹤0.01% | 1674 |
|
|
2018
Q3 | $1.27M | Sell |
44,577
-5,770
| -11% | -$138K | ﹤0.01% | 1661 |
|
|
2018
Q2 | $1.06M | Buy |
50,347
+4,371
| +10% | +$82.7K | ﹤0.01% | 1847 |
|
|
2018
Q1 | $656K | Sell |
45,976
-261
| -0.6% | -$3.74K | ﹤0.01% | 2132 |
|
|
2017
Q4 | $569K | Buy |
46,237
+5,718
| +14% | +$80.6K | ﹤0.01% | 2230 |
|
|
2017
Q3 | $722K | Buy |
40,519
+10,514
| +35% | +$217K | ﹤0.01% | 2015 |
|
|
2017
Q2 | $760K | Buy |
30,005
+16,587
| +124% | +$399K | ﹤0.01% | 1989 |
|
|
2017
Q1 | $299K | Buy |
13,418
+1,644
| +14% | +$31.6K | ﹤0.01% | 2547 |
|
|
2016
Q4 | $174K | Buy |
11,774
+410
| +4% | +$8.08K | ﹤0.01% | 2891 |
|
|
2016
Q3 | $280K | Buy |
11,364
+317
| +3% | +$7.41K | ﹤0.01% | 2509 |
|
|
2016
Q2 | $212K | Buy |
11,047
+2,503
| +29% | +$34.4K | ﹤0.01% | 2663 |
|
|
2016
Q1 | $91K | Buy |
8,544
+5,956
| +230% | +$61.5K | ﹤0.01% | 3089 |
|
|
2015
Q4 | $32 | Buy |
2,588
+2,375
| +1,115% | +$35K | ﹤0.01% | 3341 |
|
|
2015
Q3 | $3 | Buy |
+213
| New | +$4.16K | ﹤0.01% | 3768 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Manulife (Manufacturers Life Insurance)'s EVH Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Evolent Health (EVH) stake by 36% in Q1 2026, selling an estimated $55.7K and leaving 30,667 shares worth $69.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2686.
Manulife (Manufacturers Life Insurance) first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $2.06M in Q1 2024. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 30,667 shares of Evolent Health worth $69.9K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 17,544 Evolent Health shares in Q1 2026, an estimated $55.7K.
- Evolent Health made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2686 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
- Manulife (Manufacturers Life Insurance)'s Evolent Health position peaked at $2.06M in Q1 2024.
- 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.